Pipeline
Device
Medtronic USA, Inc.
Total Payments
$6.4M
Transactions
10,843
Doctors
1,381
Companies
7
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $602,799 | 2,028 | 659 |
| 2020 | $649,929 | 1,105 | 341 |
| 2019 | $1.7M | 2,194 | 396 |
| 2018 | $1.9M | 2,427 | 436 |
| 2017 | $1.5M | 3,089 | 624 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3.9M | 1,344 | 60.5% |
| Unspecified | $1.4M | 771 | 22.1% |
| Travel and Lodging | $750,051 | 2,780 | 11.8% |
| Food and Beverage | $253,745 | 5,901 | 4.0% |
| Consulting Fee | $104,850 | 36 | 1.6% |
| Grant | $2,137 | 10 | 0.0% |
| Education | $159.54 | 1 | 0.0% |
Payments by Type
General
$5.0M
10,072 transactions
Research
$1.4M
771 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PREMIER Study | Medtronic USA, Inc. | $939,591 | 7 |
| PREMIER | Medtronic USA, Inc. | $138,141 | 0 |
| BI 730357 PoCC and dose-ranging in Psoriasis | Boehringer Ingelheim International GmbH | $101,897 | 0 |
| Investigator Sponsored Research | Medtronic, Inc. | $90,038 | 0 |
| PD1 + longitudinal study | Boehringer Ingelheim International GmbH | $37,972 | 0 |
| BARREL | Medtronic USA, Inc. | $35,850 | 0 |
| Investigator Sponsored Research | Medtronic USA, Inc. | $25,313 | 0 |
| Phase 2 HR+ breast cancer xentuzumab + everolimus/exemestane | Boehringer Ingelheim International GmbH | $16,585 | 0 |
| Phase I dose escalation FIM | SCS Boehringer Ingelheim Comm.V | $5,931 | 0 |
| Artisse | Medtronic USA, Inc. | $5,000 | 0 |
| PUFS | Medtronic USA, Inc. | $3,268 | 0 |
| 1381-0001-USA1 | Boehringer Ingelheim Pharma GmbH & Co.KG | $2,420 | 0 |
| BI 730357 PoCC and dose-ranging in Psoriasis | Boehringer Ingelheim Pharma GmbH & Co.KG | $2,123 | 0 |
| PREMIER Study | Medtronic, Inc. | $1,835 | 0 |
| Pipeline Flex Japan PMS | Medtronic USA, Inc. | $800.00 | 0 |
| ARTISSE | Medtronic USA, Inc. | $425.00 | 0 |
Top Doctors Receiving Payments for Pipeline — Page 56
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Diagnostic Radiology | Poughkeepsie, NY | $6.64 | 1 |
| , M.D | Internal Medicine | Bethlehem, PA | $6.41 | 2 |
| , MD | Vascular & Interventional Radiology | Washington, DC | $5.48 | 1 |
| , M.D | Vascular Neurology | Hialeah, FL | $3.68 | 1 |
| , M.D | Orthopaedic Surgery | Los Angeles, CA | $3.26 | 1 |
| , M.D | Neuroradiology | Morgantown, WV | $2.13 | 1 |
| , M.D | Neurology | Springfield, IL | $1.86 | 1 |
Ad
Manufacturing Companies
- Medtronic USA, Inc. $5.6M
- Medtronic, Inc. $602,909
- Boehringer Ingelheim International GmbH $156,454
- Boehringer Ingelheim RCV GmbH & Co KG $14,550
- SCS Boehringer Ingelheim Comm.V $5,931
- Boehringer Ingelheim Pharma GmbH & Co.KG $4,542
- Medtronic Vascular, Inc. $1,440
Product Information
- Type Device
- Total Payments $6.4M
- Total Doctors 1,381
- Transactions 10,843
About Pipeline
Pipeline is a device associated with $6.4M in payments to 1,381 healthcare providers, recorded across 10,843 transactions in the CMS Open Payments database. The primary manufacturer is Medtronic USA, Inc..
Payment data is available from 2017 to 2021. In 2021, $602,799 was paid across 2,028 transactions to 659 doctors.
The most common payment nature for Pipeline is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3.9M, 60.5% of total).
Pipeline is associated with 16 research studies, including "PREMIER Study" ($939,591).